These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 16575722

  • 1. Emerging chloroquine-resistant Plasmodium vivax (Benign Tertian) malaria: the need for alternative drug treatment.
    Vinetz JM.
    Clin Infect Dis; 2006 Apr 15; 42(8):1073-4. PubMed ID: 16575722
    [No Abstract] [Full Text] [Related]

  • 2. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
    Maguire JD, Krisin, Marwoto H, Richie TL, Fryauff DJ, Baird JK.
    Clin Infect Dis; 2006 Apr 15; 42(8):1067-72. PubMed ID: 16575721
    [Abstract] [Full Text] [Related]

  • 3. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan.
    Kolaczinski K, Durrani N, Rahim S, Rowland M.
    Trans R Soc Trop Med Hyg; 2007 Nov 15; 101(11):1081-7. PubMed ID: 17707447
    [Abstract] [Full Text] [Related]

  • 4. Resurgence of malaria and drug resistance in Plasmodium falciparum and vivax species in Bombay.
    Sorabjee JS.
    J Assoc Physicians India; 1996 Jan 15; 44(1):71. PubMed ID: 8773108
    [No Abstract] [Full Text] [Related]

  • 5. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.
    Am J Trop Med Hyg; 2007 Nov 15; 77(5):947-54. PubMed ID: 17984359
    [Abstract] [Full Text] [Related]

  • 6. [The phenomenon of the delayed initial attack of tertian malaria].
    Silbermann MH, Stuiver PC.
    Ned Tijdschr Geneeskd; 1992 Oct 03; 136(40):1984-7. PubMed ID: 1407184
    [Abstract] [Full Text] [Related]

  • 7. Absence of nucleotide polymorphism in a Plasmodium vivax multidrug resistance gene after failure of mefloquine prophylaxis in French Guyana.
    Picot S, Brega S, Gérôme P, Velut G, de Monbrison F, Cheminel V, Peyron F.
    Trans R Soc Trop Med Hyg; 2005 Mar 03; 99(3):234-7. PubMed ID: 15653127
    [Abstract] [Full Text] [Related]

  • 8. Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
    Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F.
    PLoS Med; 2006 Jun 03; 3(6):e183. PubMed ID: 16719547
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chloroquine resistant malaria in neonates.
    Khichi QK, Channar MS, Wairraich MI, Butt A.
    J Coll Physicians Surg Pak; 2005 Jan 03; 15(1):34-6. PubMed ID: 15670522
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An open label randomized comparison of mefloquine-artesunate as separate tablets vs. a new co-formulated combination for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA, Lwin KM, McGready R, Simon WH, Phaiphun L, Proux S, Wangseang N, Taylor W, Stepniewska K, Nawamaneerat W, Thwai KL, Barends M, Leowattana W, Olliaro P, Singhasivanon P, White NJ, Nosten F.
    Trop Med Int Health; 2006 Nov 03; 11(11):1653-60. PubMed ID: 17054744
    [Abstract] [Full Text] [Related]

  • 16. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
    Esterre P, Volney B, Meynard JB, Legrand E.
    Bull Soc Pathol Exot; 2009 Aug 03; 102(3):179-84. PubMed ID: 19739416
    [Abstract] [Full Text] [Related]

  • 17. Comparative features and outcomes of malaria at a tertiary care hospital in Karachi, Pakistan.
    Beg MA, Sani N, Mehraj V, Jafri W, Khan MA, Malik A, Menezes E, Hussain R, Smego R.
    Int J Infect Dis; 2008 Jan 03; 12(1):37-42. PubMed ID: 17576086
    [Abstract] [Full Text] [Related]

  • 18. Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum.
    van Schalkwyk DA, Egan TJ.
    Drug Resist Updat; 2006 Jan 03; 9(4-5):211-26. PubMed ID: 17064951
    [Abstract] [Full Text] [Related]

  • 19. A standard regimen for treatment of plasmodium vivax malaria.
    Patwari AK.
    Indian Pediatr; 1996 Sep 03; 33(9):792-4. PubMed ID: 9057417
    [No Abstract] [Full Text] [Related]

  • 20. Chloroquine resistance in malaria.
    Goyal S, Gupta R, Bhandari B.
    Indian Pediatr; 1994 Dec 03; 31(12):1550-2. PubMed ID: 7875820
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.